Gavin MacBeath
Chief Executive Officer bij TSCAN THERAPEUTICS, INC.
Vermogen: 335 927 $ op 29-02-2024
Profiel
Founder of Merrimack Pharmaceuticals, Inc., Gavin MacBeath currently is Chief Executive Officer & Director at TScan Therapeutics, Inc.
In the past Dr. MacBeath occupied the position of Chief Scientific Officer at Abpro Corp., Senior Director & Head-Translational Research at Merrimack Pharmaceuticals, Inc. and Associate Professor at Harvard University.
Gavin MacBeath received an undergraduate degree from the University of Manitoba and a doctorate from The Scripps Research Institute.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
TSCAN THERAPEUTICS, INC.
0.11% | 13-06-2023 | 49 767 ( 0.11% ) | 335 927 $ | 29-02-2024 |
Actieve functies van Gavin MacBeath
Bedrijven | Functie | Begin |
---|---|---|
TSCAN THERAPEUTICS, INC. | Chief Executive Officer | 28-03-2023 |
Eerdere bekende functies van Gavin MacBeath
Bedrijven | Functie | Einde |
---|---|---|
ABPRO CORPORATION | Chief Tech/Sci/R&D Officer | 01-07-2018 |
MERRIMACK PHARMACEUTICALS, INC. | Founder | 01-09-2017 |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-06-2010 |
Opleiding van Gavin MacBeath
The Scripps Research Institute | Doctorate Degree |
University of Manitoba | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
TSCAN THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Abpro Corp.
Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |